[Guidelines on the management and treatment of glucocorticoid-induced osteoporosis (2004) in Japan].
Takayanagi
Ryoichi
R
Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University.
D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D002762:Cholecalciferol / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007564:Japan; D010024:Osteoporosis / Q000139:chemically induced* / Q000628:therapy*; D017410:Practice Guidelines as Topic; D012307:Risk Factors
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D005938:Glucocorticoids; D002762:Cholecalciferol